Nadim Ahmed's most recent trade in Cullinan Oncology Inc was a trade of 13,515 Common Stock done at an average price of $14.5 . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 24 Feb 2026 | 13,515 | 390,803 | - | 14.5 | 195,562 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 20 Feb 2026 | 16,381 | 404,318 | - | 13.6 | 223,109 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 828,000 | 828,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 23 Dec 2025 | 9,922 | 420,699 | - | 10.0 | 99,319 | Common Stock |
| Disc Medicine Inc | Nadim Ahmed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 12,529 | 430,621 | - | 8.5 | 106,872 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 180,000 | 443,150 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 24 Dec 2024 | 8,400 | 263,150 | - | 11.9 | 99,708 | Common Stock |
| Cullinan Oncology Inc | Ahmed Nadim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Ahmed Nadim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 160,000 | 271,550 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Ahmed Nadim | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 26 Dec 2023 | 4,272 | 111,550 | - | 9.2 | 39,473 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 28 Jun 2023 | 759 | 115,822 | - | 11.4 | 8,653 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 23 May 2023 | 707 | 116,581 | - | 9.1 | 6,469 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.59 per share. | 25 Apr 2023 | 716 | 117,288 | - | 10.6 | 7,582 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 23 Mar 2023 | 706 | 118,004 | - | 10.5 | 7,420 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 211,000 | 211,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 109,000 | 118,710 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 10.90 per share. | 30 Jun 2022 | 1,620 | 9,710 | - | 10.9 | 17,658 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 12.40 per share. | 06 Jun 2022 | 8,090 | 8,090 | - | 12.4 | 100,316 | Common Stock |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2022 | 215,000 | 215,000 | - | - | Performance Stock Unit | |
| Cullinan Oncology Inc | Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 2,710,000 | 2,710,000 | - | - | Stock Option (Right to Buy) |